Beta Blocker News and Research

RSS
Beta-adrenergic receptor blocking agents (beta-blockers) are drugs with multiple actions on the heart. Blockade of beta-1 receptors results in slowing of heart rate, reduction in myocardial contractility, and lowering of systemic blood pressure. In the context of acute myocardial infarction (AMI), which represents a state of reduced oxygen supply to the affected portion of the heart, these effects may be beneficial as they result in reduced myocardial workload and oxygen demand. Furthermore, beta-blockers may reduce the risk of ventricular arrhythmias, which are an important cause of death following AMI.
Study raises concern about the use of beta blockers for all heart patients

Study raises concern about the use of beta blockers for all heart patients

Eplerenone shows benefit for patients with damaged hearts

Eplerenone shows benefit for patients with damaged hearts

Evaluating how hospitals deliver medical care standardizes practices and improves care

Evaluating how hospitals deliver medical care standardizes practices and improves care

Nebivolol may help control high blood pressure

Nebivolol may help control high blood pressure

Vascular disease most common cause of male erectile dysfunction

Vascular disease most common cause of male erectile dysfunction

National Service Framework for chronic heart failure is urgently needed

National Service Framework for chronic heart failure is urgently needed

Atrial fibrillation may soon have an effective treatment

Atrial fibrillation may soon have an effective treatment

Diabetes knowledge has little effect on improving outcomes

Diabetes knowledge has little effect on improving outcomes

Under prescribing of statins puts more people at risk of premature death

Under prescribing of statins puts more people at risk of premature death

A drug that controls blood pressure and reduces heart risk also appears to protect against diabetes

A drug that controls blood pressure and reduces heart risk also appears to protect against diabetes

Emerging evidence supports early detection, monitoring, and in some cases treatment for children suffering from high blood pressure

Emerging evidence supports early detection, monitoring, and in some cases treatment for children suffering from high blood pressure

Polypill improves survival rates for heart disease sufferers

Polypill improves survival rates for heart disease sufferers

Drug combinations improve survival for patients with heart disease

Drug combinations improve survival for patients with heart disease

Survey of ED doctors shows team-based stroke care, risk-reducing measures, needed to increase use of tPA

Survey of ED doctors shows team-based stroke care, risk-reducing measures, needed to increase use of tPA

New GP contract may not improve treatment for heart failure patients

New GP contract may not improve treatment for heart failure patients

Heart failure patients do better when treated according to guidelines, but too many doctors still fail to prescribe the best treatments

Heart failure patients do better when treated according to guidelines, but too many doctors still fail to prescribe the best treatments

Acupuncture treatment no more effective than sham treatment in reducing migraine headaches

Acupuncture treatment no more effective than sham treatment in reducing migraine headaches

Antibiotics do not prevent heart attacks

Antibiotics do not prevent heart attacks

Genes influence how heart failure patients respond to drugs

Genes influence how heart failure patients respond to drugs

New technology and treatments for heart and lung patients drive revisions

New technology and treatments for heart and lung patients drive revisions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.